Literature DB >> 10767368

Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients.

M Ooka1, I Sakita, Y Fujiwara, Y Tamaki, H Yamamoto, T Aihara, M Miyazaki, M Kadota, N Masuda, Y Sugita, K Iwao, M Monden.   

Abstract

The aim of this study was to search for specific and sensitive mRNA markers or a combination of markers for RT-PCR detection of micrometastases in axillary lymph nodes (LNs) from patients with breast cancer. LNs (n=177) from 17 patients were examined with Cytokeratin20 (CK20), melanoma-associated genes (MAGE1, MAGE3), carcinoembryonic antigen (CEA), prostate-specific antigen (PSA), mammaglobin (MGB1) and mammaglobin B (MGB2) as molecular markers. CK20, MAGE1 and MAGE3 were slightly positive in primary tumors and CEA, PSA, MGB1 and MGB2 were highly positive. MGB1 and MGB2 were 100% positive in HE-positive LNs while CEA and PSA were only 35.7% and 57.1% positive. MGB1 and MGB2 were also 30.1% and 17.8% positive in HE-negative nodes. Thus, MGB1 and MGB2 are specific and a combination of the two should be useful for detection of micrometastases in axillary LNs of breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767368     DOI: 10.3892/or.7.3.561

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Molecular detection of breast cancer markers.

Authors:  K M Verbanac
Journal:  Mol Diagn       Date:  2001-06

2.  Comparative Proteomic Analysis of Plasma from Clinical Healthy Cows and Mastitic Cows.

Authors:  Yong-Xin Yang; Xing-Xu Zhao; Yong Zhang
Journal:        Date:  2009-10-28

3.  Relationship between mammaglobin expression and estrogen receptor status in breast tumors.

Authors:  Xiao-feng Guan; Mohammad K Hamedani; Adewale Adeyinka; Christina Walker; Angela Kemp; Leigh C Murphy; Peter H Watson; Etienne Leygue
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

4.  Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

Authors:  Barbara K Zehentner; Davin C Dillon; Yuqiu Jiang; Jiangchun Xu; Angela Bennington; David A Molesh; XinQun Zhang; Steven G Reed; David Persing; Raymond L Houghton
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

5.  Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.

Authors:  William E Gillanders; Kaidi Mikhitarian; Renee Hebert; Patrick D Mauldin; Yuko Palesch; Christian Walters; Marshall M Urist; G Bruce Mann; Gerard Doherty; Virginia M Herrmann; Arnold D Hill; Oleg Eremin; Mohamed El-Sheemy; Richard K Orr; Alvaro A Valle; Michael A Henderson; Robert L Dewitty; Sonia L Sugg; Eric Frykberg; Karen Yeh; Richard M Bell; John S Metcalf; Bruce M Elliott; Thomas Brothers; Jay Robison; Michael Mitas; David J Cole
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

6.  Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer.

Authors:  Sara Nasser; Heather E Cunliffe; Michael A Black; Seungchan Kim
Journal:  BMC Bioinformatics       Date:  2011-03-29       Impact factor: 3.169

7.  Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Authors:  S Bellone; R Tassi; M Betti; D English; E Cocco; S Gasparrini; I Bortolomai; J D Black; P Todeschini; C Romani; A Ravaggi; E Bignotti; E Bandiera; L Zanotti; S Pecorelli; L Ardighieri; M Falchetti; C Donzelli; E R Siegel; M Azodi; D-A Silasi; E Ratner; P E Schwartz; T J Rutherford; A D Santin
Journal:  Br J Cancer       Date:  2013-06-27       Impact factor: 7.640

8.  Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.

Authors:  Renata A Tassi; Stefano Calza; Antonella Ravaggi; Eliana Bignotti; Franco E Odicino; Germana Tognon; Carla Donzelli; Marcella Falchetti; Elisa Rossi; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Sergio Pecorelli; Alessandro D Santin
Journal:  BMC Cancer       Date:  2009-07-27       Impact factor: 4.430

9.  Predicting biomarkers for ovarian cancer using gene-expression microarrays.

Authors:  T R Adib; S Henderson; C Perrett; D Hewitt; D Bourmpoulia; J Ledermann; C Boshoff
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

10.  Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.

Authors:  A Nissan; D Jager; M Roystacher; D Prus; T Peretz; I Eisenberg; H R Freund; M Scanlan; G Ritter; L J Old; S Mitrani-Rosenbaum
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.